![Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load | The Brazilian Journal of Infectious Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load | The Brazilian Journal of Infectious](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1413867019304258:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qSCRz5Ib+l7k+w1jVIYLy+x9hT2kumM6W8qgi/U+qBd+ZSkUVK08WrCDiDbtm65i1Rh+CBQ4dxPRg2UEmDWvSrd5eoXwh+7d3pNu7wnhTcqMXrMndLmXv0+23PQiLesCioWNDyQZtU1Z+GE2I2WmU1PQDvnSUshOHOuhERZ+zoJfLIkRPwx3wN7siIyslhYipEyGuK9SeimGvEHRZqFxkc56RLbXEuzRYwT2qWIfU2/0kYmbs23xJ+h8O4U+V5q5AoJcqqG9LhfsIpEzPjLJs=)
Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load | The Brazilian Journal of Infectious
![Vaccines | Free Full-Text | Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice | HTML Vaccines | Free Full-Text | Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice | HTML](https://www.mdpi.com/vaccines/vaccines-10-01323/article_deploy/html/images/vaccines-10-01323-g001.png)
Vaccines | Free Full-Text | Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice | HTML
![Significance of anti-HBc alone serological status in clinical practice - The Lancet Gastroenterology & Hepatology Significance of anti-HBc alone serological status in clinical practice - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/00c8b4fd-16c0-4b35-b3d4-405850e6375e/gr1_lrg.jpg)
Significance of anti-HBc alone serological status in clinical practice - The Lancet Gastroenterology & Hepatology
![VIDAS Hepatitis panel, hepatitis diagnosis and testing (A,B, C and E) | bioMérieux Clinical Diagnostics VIDAS Hepatitis panel, hepatitis diagnosis and testing (A,B, C and E) | bioMérieux Clinical Diagnostics](https://www.biomerieux-diagnostics.com/sites/clinic/files/hep-1.jpg)
VIDAS Hepatitis panel, hepatitis diagnosis and testing (A,B, C and E) | bioMérieux Clinical Diagnostics
![SciELO - Brasil - The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers The biological meaning of anti-HBC positive result in blood donors: SciELO - Brasil - The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers The biological meaning of anti-HBC positive result in blood donors:](https://minio.scielo.br/documentstore/1678-9946/NDxtZT9hV4br6ycjcj9SD8g/cc0a2fbeac3e065511c73ad7f2cf3f88f9e0fb49.gif)
SciELO - Brasil - The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers The biological meaning of anti-HBC positive result in blood donors:
![Anti-HBV protein IgG responses of vaccinated tree shrews. (A, C, E)... | Download Scientific Diagram Anti-HBV protein IgG responses of vaccinated tree shrews. (A, C, E)... | Download Scientific Diagram](https://www.researchgate.net/publication/336140067/figure/fig1/AS:864357252616192@1583090236445/Anti-HBV-protein-IgG-responses-of-vaccinated-tree-shrews-A-C-E-Anti-HBs-S-A.png)
Anti-HBV protein IgG responses of vaccinated tree shrews. (A, C, E)... | Download Scientific Diagram
![Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. - Abstract - Europe PMC Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6039383/bin/nihms977087f2.jpg)
Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. - Abstract - Europe PMC
![SciELO - Brasil - Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008 Anti-HBs levels among SciELO - Brasil - Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008 Anti-HBs levels among](https://minio.scielo.br/documentstore/1678-9849/mvvTDkj9Mwc5Ld3CKddnBjH/3831cd441d6b6e5628bd0cc7af0eb67412dd4c97.jpg)
SciELO - Brasil - Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008 Anti-HBs levels among
Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults | PLOS ONE
![Anti-HBs (Hepatitis B immune status/Anti-Hepatitis B surface antibody) | Newfoundland & Labrador Public Health Laboratory Anti-HBs (Hepatitis B immune status/Anti-Hepatitis B surface antibody) | Newfoundland & Labrador Public Health Laboratory](https://publichealthlab.ca/wp-content/uploads/2012/09/Anti-HBs-Chart-2.jpg)
Anti-HBs (Hepatitis B immune status/Anti-Hepatitis B surface antibody) | Newfoundland & Labrador Public Health Laboratory
Metodologia de supraveghere a hepatitelor virale tip B si C Actualizare 30 ianuarie 2017 la pag. 8 -„Nota” si la pag. 12 –
![Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial | AIDS Research and Therapy Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial | AIDS Research and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12981-019-0249-8/MediaObjects/12981_2019_249_Fig1_HTML.png)
Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial | AIDS Research and Therapy
![Frontiers | Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming in silico Hypothesis Frontiers | Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming in silico Hypothesis](https://www.frontiersin.org/files/Articles/909660/fmed-09-909660-HTML-r1/image_m/fmed-09-909660-g001.jpg)